Pharmacological components include at least one vasculopathy receptor blocker and at least one vasculogenin receptor V1A/V2 pair; and for the treatment of hypertension, congestive heart failure, heart ischemia, kidney disease, thrombosis, etc.

摘要

Pharmaceutical composition comprising at least an angiotensin receptor blocker (ARB) and at least one antagonist Receptor V1a / V2 vasopressin; and their use for treating hypertensionCongestive heart failure, Cardiac ischemia, renal disease, thrombosis, among others.